PharmaRadar360
PharmaRadar360
Intelligence Layer
🇺🇸·23h agoResearch

Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide

Publisher

P
PubMed Annals of Internal Medicine RSS

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on pubmed.ncbi.nlm.nih.gov

Leave the platform to read the original full article on the publisher site.

Source: PubMed Annals of Internal Medicine RSS

Scope: Research

Open original article
Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide | PharmaRadar360